RegeneRx’s Tβ4 Significantly Improves Functional Recovery in MS Animal Model

BETHESDA, Md.–REGENERX BIOPHARMACEUTICALS, INC. (NYSE Amex:RGN) announced today that researchers at the Henry Ford Health System in Detroit, Michigan, demonstrated for the first time that Tβ4 treatment [...]

• Caroline says: This is good stuff...we shouldn't get too excited because mouse MS (EAE) and human MS are very different...animals (pardon the pun). According to this study, in animals with EAE, RegeneRx improved neurological function, reduced inflammatory infiltrates in the brain, and increased oligodendrocyte progenitor cells (a type of stem cell) and mature oligodendrocytes in the brain. I don't know what some of that means, but it sounds groovy to me.
   

• Related Links:
• http://www.businesswire.com/portal/site/google/?ndmViewId=news_view&newsId=20090…